BKGR Urges Investors to Subscribe to T2S IPO, Target Price Set at 274 DH

BMCE Capital Global Research (BKGR) has given a strong ‘subscribe’ recommendation for the T2S Group Holding IPO at a subscription price of 223 DH per share, setting a target price of 274 DH and implying a 22.6 % upside. The research highlights T2S’s integrated medical‑technology platform, diversified revenue streams, and strategic position in a fast‑growing Moroccan health‑care market, while also outlining the key catalysts and risks that could shape its performance through 2030.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.